Schmitt, M;Sturmheit, AS;Welk, A;Schnelldorfer, C;Harbeck, N
Procedures for the quantitative protein determination of urokinase and its inhibitor, PAI-1, in human breast cancer tissue extracts by ELISA.
Methods Mol Med
2006
120
245-65

Morrison, JE;Jacobs, VR
Classic intrafascial supracervical hysterectomy (CISH): 10-year experience.
JSLS
2006
10
1
26-9

Jacobs, VR;Morrison, JE
Application of a locally placed anesthesia catheter for reduction of postoperative pain after mastectomy for breast cancer.
Int J Fertil Womens Med
2006
51
5
225-9

Stemmler, J;Schmitt, M;Willems, A;Bernhard, H;Harbeck, N;Heinemann, V
Brain metastases in HER2-overexpressing metastatic breast cancer: Comparative analysis of trastuzumab levels in serum and cerebrospinal fluid.
J Clin Oncol
2006
24
18
64S-64S

Artmann, A;Heyne, M;Kiechle, M;Harbeck, N
Breast self examination training and counseling as motivation strategies for breast awareness and participation in breast cancer screening programs.
J Clin Oncol
2006
24
18
55S-55S

Thussbas, C;Nährig, J;Streit, S;Bange, J;Kates, R;Ulm, K;Kiechle, M;Hoefler, H;Ullrich, A;Harbeck, N
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
J Clin Oncol
2006
24
18
34S-34S

Llombart-Cussac, A;Martin, M;Harbeck, N;Anghel, R;Eniu, A;Melemed, A;Clark, R;Simms, L;Kaiser, C;Ma, D
Randomized, phase II study of two doses of pemetrexed as first-line chemotherapy for locally advanced or metastatic breast cancer (MBC): Clinical results and exploratory pharmacogenomic analysis.
J Clin Oncol
2006
24
18
140S-140S

Kiechle, M;Meindl, A
Hereditary breast and ovarian cancer
Geburtsh Frauenheilk
2006
66
6
545-548

Kates, R;Allgayer, H;Harbeck, N
Hierarchical neural net technology for molecular staging with clinical data
Eur J Cancer
2006
4
6
9-9

Schmitt, M;Harbeck, N;Foekens, J;Maier, S
DNA-methylation markers and YB-1 as indicators of therapy response in breast cancer
Eur J Cancer
2006
4
6
11-12